Thursday, April 30, 2026 12:15:03 PM
"What do you expect the company to do!?"
I've heard the same argument for years now. How about more updates from the company? Do something to put eyes on the company. Its LP choice to only PR material events. We were told it was to cut down on material that can be used against them. I call BS. The silence is being used against them.
So what should they be more vocal about? How about some news on the international patents they own. How about highlighting milestones and anniversaries of long time survivors. How about some success stories. How about construction news. How about LL doing a round of information tours at various hospitals.
Yes, that information is in the company reports, but unless you follow the company, why would you read the reports? We need to attract new investors. As limited as the big biz podcast was, it was better than nothing. These ideas are off the top of my head, so why not hire another PR firm. I'm not the one on payroll. And for all those who will pick apart these ideas, remember, we are at 20 cents. IMO the silent method does not seem to be working. How about a 60 minutes story, with a tour of the company. First new treatment for GBM in 20 years with a potential for all solid tumors sounds newsworthy to me. After nick shirleys success, I'm sure they can find a podcast reporter to focus on NWBO and give youtube updates.
Oh yeah, my favorite is "we don't want to upset the MHRA". After 2 1/2 years, I don't think that should be their main worry. Attracting new investors should be a priority. Just my 2 cents based on frustration. Selling 5k more shares as soon as it hits .21, down to 35k now.
I've heard the same argument for years now. How about more updates from the company? Do something to put eyes on the company. Its LP choice to only PR material events. We were told it was to cut down on material that can be used against them. I call BS. The silence is being used against them.
So what should they be more vocal about? How about some news on the international patents they own. How about highlighting milestones and anniversaries of long time survivors. How about some success stories. How about construction news. How about LL doing a round of information tours at various hospitals.
Yes, that information is in the company reports, but unless you follow the company, why would you read the reports? We need to attract new investors. As limited as the big biz podcast was, it was better than nothing. These ideas are off the top of my head, so why not hire another PR firm. I'm not the one on payroll. And for all those who will pick apart these ideas, remember, we are at 20 cents. IMO the silent method does not seem to be working. How about a 60 minutes story, with a tour of the company. First new treatment for GBM in 20 years with a potential for all solid tumors sounds newsworthy to me. After nick shirleys success, I'm sure they can find a podcast reporter to focus on NWBO and give youtube updates.
Oh yeah, my favorite is "we don't want to upset the MHRA". After 2 1/2 years, I don't think that should be their main worry. Attracting new investors should be a priority. Just my 2 cents based on frustration. Selling 5k more shares as soon as it hits .21, down to 35k now.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
